next up previous contents
Next: 8 Population Distribution of Up: PAGE '95: ABSTRACT LIST Previous: 6 Population of Vancomycine

7 Sufentanyl Pharmacokinetic-Pharmacodynamic Modelling (PK/PD) on NONMEM in 10 Patients with Coronary Surgery

 

D. Breilh(1) , C. Pobel(1) , C. Roth(2) , M.C. Saux(1) , G.Janvier(2)

Laboratory of Clinical Pharmacokinetic, Bordeaux II University, France(1)
Anaesthesiology ward, Haut-Leveque hospital, Bordeaux II University, France(2)

10 patients were investigated. Their average characteristics are: age 658.7 years, weight 75.79.9 kg. They were given an average total dose of 40969.67 mg/kg of sufentanyl during anaesthesia: 6 mg/kg from induction to sternotomy (one or several bolus), and 1 mg/kg in continue with an electric seringe to increase the duration of anaesthesia. Blood samples mean is 182.7 per patient (extreme: 15-23) and blood sampling was done between 0 and 18 hours after anaesthesia was induced and depends on the duration of the operation.

Pharmacological effects studied are haemodynamic as the mean arterial blood pressure (MAP) was taken in each patient when blood samples were taken. The PK/PD model is a two-compartment pharmacokinetic model, whose central compartment is linked to the effect compartment. The sigmoid Emax model (Hill's equation) as well as a linear model have been used for studying the relationship between the effect (E%) and the concentration in the effect compartment. Results (on model plasma concentration):

The values of parameters (K10, K12, K21) are similar between the Emax model and the linear model. The biophase can be put on the central level with these results. This is interesting as far as the MAP is a very easy parameter to follow in anaesthesia and is a means of controlling the quality of anaesthesia.



harnisch@pollux.zedat.fu-berlin.de